2 "Acute Myelogenous Leukemia" clinical trials found.

• 

  UPCC 11417: A Phase 3 Multicenter Randomized Open-Label Study of Guadecitabine (SGI-110) versus Treatment Choice in Adults with Previously Treated ...

  Request for collaborative review: WIRB serving as IRB of record.

  Exact  Phase  James Mangan

• UPCC 44419: Randomized Trial of Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia (AML)

  The purpose of this study is to compare the effectiveness of gilteritinib to midostaurin in patients receiving standard combination chemotherapy ...

  Exact  Phase  Alexander Perl